GNF-4256 inhibits the phosphorylation of TRK-B in a dose-dependent manner and has antiproliferative activity on TRK-B-expressing human NB cells (SY5Y-TRK-B), with an IC50 value of 50 nM. Here, NTRK2 is linked to neuroblastoma.